Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial

2017 ◽  
Vol 20 (3) ◽  
pp. 590-598 ◽  
Author(s):  
Jingtao Dou ◽  
Jianhua Ma ◽  
Jun Liu ◽  
Changjiang Wang ◽  
Eva Johnsson ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Initial Therapy ◽  
Chinese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind

18-OR: Efficacy and Safety of Chiglitazar vs. Sitagliptin in Patients with Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Noninferiority Phase 3 Trial (CMAS)

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 18-OR
Author(s):  
WEIPING JIA ◽  
JIANHUA MA ◽  
HENG MIAO ◽  
CHANGJIANG WANG ◽  
XIAOYUE WANG ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind

scholarly journals A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes

2015 ◽  
Vol 62 (5) ◽  
pp. 449-462 ◽  
Author(s):  
Hae Kyung Yang ◽  
Kyung Wan Min ◽  
Sung Woo Park ◽  
Choon Hee Chung ◽  
Kyong Soo Park ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document